
WILLIAMS LOST
31 lbs
KENYAN FOLLOWERS
100K+
AFRICAN MARKETS
3
ORIGINAL INDICATION
Type 2
GLP-1 receptor agonists — Ozempic, Mounjaro, and their proliferating cousins — were designed to manage type 2 diabetes by mimicking the glucagon-like peptide-1 hormone. They regulate blood sugar, slow digestion, and suppress appetite. The health case is real: diabetes devastates Black communities from Sudan to the Caribbean, where socioeconomic factors compound genetic risk and the disease drives outcomes from loss of consciousness to amputation. Emerging research links GLP-1s to reduced addiction risk and lower breast cancer incidence. On the medical ledger, these drugs are genuinely generative.
Extraction Map
But the drugs have escaped their clinical lane. Across the African continent, uptake is accelerating fastest in countries with growing middle classes — South Africa, Ghana, Kenya — where privately prescribed GLP-1s function as class signifiers. In Nairobi, one weight-loss drug user told the BBC that 'big size' had been the fashion, but now the trend is to be 'slim, tiny.' A Kenyan influencer with hundreds of thousands of followers has documented her liposuction and injections in granular detail, with followers saving up to replicate the process. The drugs are not merely medical tools; they are status goods that encode global beauty norms into local aspiration. The celebrity pipeline accelerates the shift. Oprah Winfrey's decades-long public weight struggle ended with GLP-1s. Serena Williams — an archetype of powerful, muscular Black womanhood who endured years of public scrutiny and bullying for her physique — recently starred in GLP-1 adverts for telehealth company Ro, announcing she was down 31 pounds and declaring it was 'what my body needed' after kids. When cultural figures who once embodied body-diverse ideals become pharmaceutical spokespeople, the permission structure for the rest of the population collapses. The extraction pattern is layered. Novo Nordisk and Eli Lilly capture pharmaceutical revenue. Telehealth platforms like Ro capture distribution margins. Influencers capture engagement. What gets extracted from the other end is harder to quantify but structurally real: culturally specific beauty standards that provided psychological resilience for Black women — Sudanese wedding traditions of feeding brides, Caribbean body positivity, the broader diasporic comfort with fuller figures — are being replaced by a homogenised ideal. The emerging 2020s beauty standard blends traditionally Black and white-coded features into what the author calls 'a hybrid of insecurity': slight frame, small waist, slim nose, but with full lips, sculpted cheekbones, and augmented buttocks. The class dimension is the sharpest edge. GLP-1s remain privately prescribed and expensive across most of Africa and the Caribbean, which means access tracks wealth. Weight loss becomes a visible marker of disposable income, layering class aspiration onto body aspiration. This is not a story about individual choice — it is a story about how pharmaceutical distribution channels, influencer economies, and celebrity endorsement pipelines interact to export a monoculture of thinness into communities that historically maintained alternative standards. The honest tension the piece identifies is real and unresolvable: diabetes kills, and GLP-1s save lives. The author's own grandmother died young from a diabetes-related illness. Nobody credible argues these drugs should not exist. The question is whether the cosmetic use case — driven by class signalling and global beauty homogenisation — will overwhelm the medical one, and whether the cultural commons of body diversity can survive contact with a pharmaceutical product that makes thinness purchasable. The answer, twenty years out, is probably not. Appended to the newsletter: Black Irish readers responded to the death of Yves Sakila, a Congolese man who died in Ireland after being pinned down by security guards for almost five minutes. Miriam Boosh of Carlow described escalating racial harassment and the burden of constantly defending her Irishness. David Bakare of Roscommon spoke of the sadness hanging over Black Irish communities. Both testimonies underscore the gap between Ireland's self-image as uniquely welcoming and the lived experience of its Black citizens.
Worth reading?
SKIP
Score
36
/100
Mixed — medically generative for diabetes management, but cosmetic use case is extractive, converting culturally diverse beauty standards into pharmaceutical revenue and homogenised body norms that track class.
What Is GRIN?
GRIN stands for Generativity, Resilience, Innovation efficiency, and Novelty openness. These four dimensions capture the essential characteristics of any memetic intelligence — whether a nation, a corporation, a religion, or a movement.
About GRINGenerativity
2/5
Resilience
1/5
Efficiency
2/5
Novelty
2/5
Extractive
3/5
Inverted
Does this create new capability or just redistribute existing value?
Split verdict. Diabetes treatment is genuinely generative — lives saved, amputations prevented. But cosmetic adoption creates no new capability; it redistributes cultural value from body diversity toward pharma revenue and a monoculture of thinness.
Verified Facts (11)
GLP-1 medications mimic a natural hormone called glucagon-like peptide-1, initially designed to manage type 2 diabetes
GLP-1s touted to treat addiction (Washington University study) and lower breast cancer risk (Penn Medicine)
Accelerating use of weight-loss drugs reported in South Africa, Ghana, and Kenya
Serena Williams starred in GLP-1 adverts for telehealth company Ro, reporting she was down 31 pounds
Williams said: 'After kids, it was what my body needed'
Nairobi weight-loss drug user told the BBC: 'Big size' had been the fashion but now the trend is 'slim, tiny'
Kenyan influencer with hundreds of thousands of Instagram followers documented liposuction and injections
Author is Sudanese; describes pre-wedding tradition of feeding brides thick pudding
Author's grandmother died young from a diabetes-related illness
Yves Sakila, a Congolese man, died in Ireland after being pinned down by security guards for almost five minutes
Reader testimonies from Miriam Boosh (Carlow) and David Bakare (Roscommon) on race in Ireland
More latest news
Read all